NYOH patients who need documentation to confirm eligibility to receive the COVID-19 vaccine, visit our COVID-19 resource page to learn how.
Learn More

Clinical Trials & Research

EndoPredict (EXET) Breast Registry study

EndoPredict® Extended Endocrine Trial (EXET): A prospective registry to evaluate the impact of EndoPredict® in decisions regarding extended endocrine treatment (ONC-010)

Disease Types: Breast,&nbs

Available at: {clinical_trial_location backspace="7"}EndoPredict (EXET) Breast Registry study, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}